Regarding CXCL11, its mRNA upregulation was associated with a better prognosis in several cancers, and PD-L1 blockade combined with an oncolytic vaccinia virus expressing CXCL11 in mouse models was shown to considerably decrease tumor burden and improve prognosis [50,51]. This evidence concerns the gene CXCL11 and neoplasm.